Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma

Krook, MA; Lenyo, AM; Wilberding, MJ; Barker, HD; Dantuono, M; Chen, HZ; Reeser, JW; Wing, MR; Miya, J; Samorodnitsky, E; Smith, AM; Dao, T; Martin, DM; Dittmar, K; Ciombor, KK; Hays, JL; Freud, AG; Roychowdhury, S

CANCER RESEARCH, 2019; 79 (13):